Kyrgyzstan vs East Timor: Average non-HDL cholesterol levels
Kyrgyzstan
3.2
in 2018
East Timor
3.2
in 2018
Kyrgyzstan rank
118th
East Timor rank
118th
Average non-HDL cholesterol levels over time
- Kyrgyzstan
- East Timor
How they compare
Kyrgyzstan currently reports 3.2 against 3.2 in East Timor, a difference of 0.
The two have swapped places 1 time across 39 shared years of data; in 1980 it was Kyrgyzstan ahead.
Kyrgyzstan ranks 118th and East Timor ranks 118th of 191 countries.
Kyrgyzstan has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Kyrgyzstan | East Timor | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.1 | 2.68 | 0.42 | Kyrgyzstan |
| 1990s | 3.1 | 2.89 | 0.21 | Kyrgyzstan |
| 2000s | 3.1 | 3.06 | 0.04 | Kyrgyzstan |
| 2010s | 3.16 | 3.16 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average non-hdl cholesterol levels, Kyrgyzstan or East Timor?
- Kyrgyzstan, at 3.2 against 3.2 in East Timor as of 2018.
- What is the difference in average non-hdl cholesterol levels between Kyrgyzstan and East Timor?
- 0, with Kyrgyzstan ahead.
- How many years of comparable data are there for Kyrgyzstan and East Timor?
- 39 years are reported by both, from 1980 to 2018.
- How do Kyrgyzstan and East Timor rank globally for average non-hdl cholesterol levels?
- Kyrgyzstan ranks 118th and East Timor ranks 118th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated average level of non-high-density lipoprotein (non-HDL) cholesterol, commonly known as "bad cholesterol". Healthy levels are considered to be under 4mmol/L. Elevated levels of non-HDL cholesterol are a risk factor for chronic complications, including cardiovascular disease, and premature death.